OBSERVATIONAL STUDY TO EVALUATE THE OUTCOME OF PRESCREEN FAILURE AND SCREEN FAILURE PATIENTS WHO RECEIVE CHEMORADIATON FOR LOCALLY ADVANCED HEAD AND NECK CANCER

Tata Memorial Hospital0 个研究点目标入组 1,500 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Histological or cytological proven diagnosis of squamous cell or undifferentiated carcinoma of the head and neck region or squamous cell carcinoma of the head and neck region of unknown primary.
•2. Planned for or has received curative intent concurrent chemoradiotherapy, either in the definitive or adjuvant setting.
•3. Prescreen failure or screen failure of trial no 838/ 937

•1. Recruited on either of below mentioned protocol:
•i) Phase III non-inferiority randomized trial comparing three-weekly Cisplatin versus weekly Cisplatin in combination with radiation therapy in patients with advanced carcinoma of the head and neck( TMH NO-937)
•ii) â??An Open label, Randomized, Investigator Initiated Multicentric, Phase III Study of Nimotuzumab in combination with Concurrent Radiotherapy and Cisplatin versus Radiotherapy and Cisplatin alone, in Subjects with Locally advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)â?? (TMH NO: 838)

发起方